How is the government increasing capacity in line with population growth?
Displaying 247 - 252 of 1326
Interviews & Viewpoints | Kwaku Agyeman-Manu, Minister of Health: Interview from The Report: Ghana 2019
Articles & Analysis | New education strategy helps Ghanaian graduates meet job market needs from The Report: Ghana 2019
Ghana’s government has prioritised educational reform in recent years in a bid to improve access at all levels of the system. To this end, in 2018 the state introduced its Free Senior High School (SHS) policy, an initiative which provides free tuition for attendees at all public secondary schools. On top of this, to improve learning outcomes...
Chapter | Health & Education from The Report: Ghana 2019
Ghana’s economic development is leading to heightened demand for specialised private health services, while on the public side; the government has made commitments to improve universal health coverage and is implementing plans to tackle specific challenges such as non-communicable diseases and a shortage of health professionals. Such commitments to legal reform and public resource provision will...
Ghana continues to be one of the most stable countries in sub-Saharan Africa and has developed substantially over the years. Now one of Africa’s fastest-growing economies, the country is starting to move away from traditional resource dependency. However, it faces the challenge of ensuring the widest benefit from that expansion, given its growing and increasingly urbanised population.
Interviews & Viewpoints | Dr Mariam Al Jalahma, CEO, National Health Regulatory Authority (NHRA): Interview from The Report: Bahrain 2019
How are regulation and licensing changing as the private sector becomes involved in health care?
Articles & Analysis | Expansion of health care provision in Bahrain is boosting demand for local and imported pharmaceuticals from The Report: Bahrain 2019
The pharmaceutical market has expanded its geographical reach in recent decades, and this trend appears to be here to stay. In a survey of major pharmaceutical firms conducted by global consulting firm PwC’s Strategy team, more than half of respondents anticipated that over 30% of their global sales would originate in emerging markets by 2018...